{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 460793422
| IUPAC_name = (5α,7α)-17-(Cyclopropylmethyl)- 4,5-epoxy- 18,19-dihydro- 3-hydroxy- 6-methoxy- α,α-dimethyl- 6,14-ethenomorphinan- 7-methanol
| image = Diprenorphine.svg
| width = 180

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|diprenorphine}}
| pregnancy_AU =  
| pregnancy_US =  
| pregnancy_category =  
| legal_AU =  
| legal_CA =  
| legal_UK =  
| legal_US = 
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 14357-78-9
| ATCvet = yes
| ATC_prefix = V03
| ATC_suffix = AB92
| PubChem = 443408
| IUPHAR_ligand = 1617
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01548
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 391634
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 1F0L5N25ZZ
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07863
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 281786

<!--Chemical data-->
| C=26 | H=35 | N=1 | O=4 
| molecular_weight = 425.56 g/mol
| smiles = CC(C)([C@H]1C[C@@]23CC[C@@]1([C@H]4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C26H35NO4/c1-23(2,29)18-13-24-8-9-26(18,30-3)22-25(24)10-11-27(14-15-4-5-15)19(24)12-16-6-7-17(28)21(31-22)20(16)25/h6-7,15,18-19,22,28-29H,4-5,8-14H2,1-3H3/t18-,19-,22-,24-,25+,26-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = OIJXLIIMXHRJJH-KNLIIKEYSA-N
| melting_point =  
| melting_high =  
}}
'''地利洛非'''也称为'''二丙诺啡'''，是{{le|μ-阿片受体|μ-opioid receptor|μ-}}（MOR），{{le|κ-阿片受体|κ-opioid receptor|κ-}}（KOR）和{{le|δ-阿片受体|δ-opioid receptor|δ-}}阿片受体（DOR）（三者具有相同的亲和力）的非选择性，高亲和力，弱[[部分激动剂|部分激动剂]]，同时在兽医学中用作{{le|阿片类拮抗剂|opioid antagonist}}。<ref>{{Cite book|url=https://www.worldcat.org/oclc/31604964|last=Anat.|first=Biegon,|last2=1956-|first2=Volkow, Nora D.,|date=1995|publisher=CRC Press|isbn=084937653X|location=Boca Raton|chapter=Sites of drug action in the human brain|oclc=31604964}}</ref><ref>{{Cite book|url=https://www.worldcat.org/oclc/475936876|last=Simon.|first=Shorvon,|last2=E.|first2=Dodson, W.|date=2007|publisher=John Wiley & Sons|isbn=9780470752456|edition=2nd ed|location=Oxford|chapter=The Treatment of Epilepsy.|oclc=475936876}}</ref>它用于逆转超强效阿片类镇痛药的作用，例如用于镇静大型动物的{{le|埃托啡|etorphine}}和{{le|卡芬太尼|carfentanil}}。该药物未被批准用于人类。<ref>{{Cite book|url=https://www.worldcat.org/oclc/860862503|last=W.),|first=Clarke, K. W. (Kathy|last2=M.),|first2=Trim, C. M. (Cynthia|isbn=9780702057311|edition=Eleventh edition|location=Edinburgh|chapter=Veterinary anaesthesia|oclc=860862503}}</ref>

地利洛非是市场上最强的阿片类拮抗剂（作为拮抗剂的效力比[[納洛酮|纳洛芬]]高100倍），并且用于逆转非常强的阿片类物质的作用是，其结合亲和力如此之高以至于[[納洛酮|纳洛酮]]不能有效或可靠地逆转麻醉作用。这些超强效的阿片类药物，除了丁丙诺啡以外（由于其部分激动作用而具有改善的安全性），因为人体剂量太小难以正确测量，因此不会用于人体。 因此过量服用的风险会导致致命的呼吸抑制。然而，常规阿片类衍生物的镇静强度不足以使大型动物（如大象和犀牛）迅速镇静，因此埃托啡和卡芬太尼等药物可用于此目的。

因为地利洛非是阿片受体的弱部分激动剂而不是沉默拮抗剂，可以在没有其他足够剂量的阿片类药物的情况下产生一些阿片类药物作用。<ref>{{Cite book|url=https://www.worldcat.org/oclc/184983321|last=Sarah.|first=Wolfensohn,|last2=service)|first2=Wiley InterScience (Online|date=2003|publisher=Blackwell Pub|isbn=9780470751077|edition=3rd ed|location=Oxford, UK|chapter=Handbook of laboratory animal management and welfare|oclc=184983321}}</ref>此外，由于具有KOR的部分激动作用，它似乎相对于MOR具有显着更大的内在活性，因此地利洛非可以产生镇静作用，并且在人类中也可以产生幻觉。<ref>{{Cite book|url=https://www.worldcat.org/oclc/743316519|last=Eric.|first=Miller, R.|last2=E.|first2=Fowler, Murray|date=2012|publisher=Elsevier/Saunders|isbn=9781437719864|edition=Vol. 7 [i.e. 7th ed.]|location=St. Louis, Mo.|chapter=Fowler's zoo and wild animal medicine : current therapy|oclc=743316519}}</ref><ref>{{Cite book|url=https://www.worldcat.org/oclc/948021007|last=S.|first=Harrie, Louie|date=1998|publisher=Diane Pub Co|isbn=0788181300|location=[Place of publication not identified]|chapter=Problems of drug dependence : 1996 proceedings of the 59th annual scientific symposium.|oclc=948021007}}</ref><ref>{{Cite journal|title=Diprenorphine has agonist activity at opioid κ-receptors in the myenteric plexus of the guinea-pig ileum|url=http://linkinghub.elsevier.com/retrieve/pii/0014299987901853|last=Traynor|first=J.R.|last2=Corbett|first2=A.D.|date=1987-05|journal=European Journal of Pharmacology|issue=1|doi=10.1016/0014-2999(87)90185-3|volume=137|pages=85–89|issn=0014-2999|last3=Kosterlitz|first3=H.W.}}</ref>

== 参考文献 ==
<references />

{{解毒剂}}
[[Category:阿片拮抗剂|Category:阿片拮抗剂]]
[[Category:吗啡|Category:吗啡]]
[[Category:半合成阿片类药物|Category:半合成阿片类药物]]
[[Category:醚|Category:醚]]